Alcami, a leading product development and manufacturing services provider for the pharmaceutical and biotechnology sectors, plans to finish relocating its international headquarters from Wilmington to Durham in 2018.
The company says it will continue to operate its laboratory in Wilmington, while transitioning its executive team to the Research Triangle Park area.
Today, it employs 50 people at its Durham location. However, it expects this number to grow as it expands its technology into biologics. Executives will continue to work out of the Wilmington and Durham offices until the company completes the transition in 2018.
“We are very excited about this relocation, which prominently positions Alcami in a region known for its culture of diverse expertise, cutting-edge innovation and invention,” said Stephan Kutzer, Ph.D., Alcami president and CEO. “Our stronger presence in the Triangle is necessary to meet the evolving needs of our clients, accommodate growth, recruit top talent and attract investors and new customers.”
Alcami remains committed to its operations in Wilmington, which accounts for approximately 35 percent of the company’s overall business. The company recently invested more than $6 million to expand its facilities there, where it employs 450 people.
The company employs more than 1,000 people at seven sites around the world.